These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22884154)

  • 21. Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin.
    Wilson KM; Smith AI; Phillips DJ
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):30-5. PubMed ID: 16697104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.
    Bousette N; Pottinger J; Ramli W; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    Peptides; 2006 Nov; 27(11):2919-26. PubMed ID: 16919371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species.
    Lijnen P; Papparella I; Petrov V; Semplicini A; Fagard R
    J Hypertens; 2006 Apr; 24(4):757-66. PubMed ID: 16531806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
    Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
    J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS; Agata J; Xia CF; Chao L; Chao J
    Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of angiotensin II on collagen metabolism in cultured rat cardiac fibroblasts: its relation to cardiac hypertrophy].
    Sano H
    Hokkaido Igaku Zasshi; 1994 Jan; 69(1):25-34. PubMed ID: 8119655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of activin A synthesis in microglial cells: pathophysiological implications for bacterial meningitis.
    Wilms H; Schwark T; Brandenburg LO; Sievers J; Dengler R; Deuschl G; Lucius R
    J Neurosci Res; 2010 Jan; 88(1):16-23. PubMed ID: 19681171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
    Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
    Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
    Ota F; Maeshima A; Yamashita S; Ikeuchi H; Kaneko Y; Kuroiwa T; Hiromura K; Ueki K; Kojima I; Nojima Y
    Arthritis Rheum; 2003 Sep; 48(9):2442-9. PubMed ID: 13130463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury.
    Chen Y; Rothnie C; Spring D; Verrier E; Venardos K; Kaye D; Phillips DJ; Hedger MP; Smith JA
    Cytokine; 2014 Oct; 69(2):255-62. PubMed ID: 25052838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts.
    Yu XY; Qiao SB; Guan HS; Liu SW; Meng XM
    Horm Metab Res; 2010 Jun; 42(7):507-13. PubMed ID: 20225169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnolol depresses urotensin-II-induced cell proliferation in rat cardiac fibroblasts.
    Liou JY; Chen YL; Loh SH; Chen PY; Hong CY; Chen JJ; Cheng TH; Liu JC
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):711-6. PubMed ID: 19207719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of calcium-calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion.
    Zhang W; Chen DQ; Qi F; Wang J; Xiao WY; Zhu WZ
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):96-105. PubMed ID: 19935079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.